Ferring Pharmaceuticals US is recalling the following desmopressin nasal spray products for possible superpotency identified during routine product testing.
Recall of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE Nasal Spray 1.5 mg/mL by Ferring Pharmaceuticals US due to superpotency.
Manufacturers are being required by the FDA to add recommendations about naloxone to prescribing information for all opioids, including buprenorphine and methadone which are used to treat opioid use disorder...
Two lot numbers of dexmedetomidine hydrochloride (Precedex) 200 mcg/50 ml injection have been recalled by Fresenius Kabi USA due to the potential of lidocaine contamination.
Recall of Children's Robitussin Honey Cough and Chest Congestion DM and Children's Dimetapp Cold and Cough by GSK due to dosing cups missing graduation markings.
FDA released a safety alert regarding the possible reduced antiviral activity of remdesivir when administered concomitantly with hydroxychloroquine sulfate or chloroquine phosphate.